Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

Konermann, Silvana; Brigham, Mark D.; Trevino, Alexandro E.; Joung, Julia; Abudayyeh, Omar O.; Barcena, Clea; Hsu, Patrick D.; Habib, Naomi; Gootenberg, Jonathan S.; Nishimasu, Hiroshi; Nureki, Osamu; Zhang, Feng

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.

Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

Dec 10 2014
By Konermann, Silvana ; Brigham, Mark D. ; Trevino, Alexandro E. ; ...
Source: Nature. 517(7536):583-588.

[PDF-6.41 MB]

Select the Download button to view the document

This document is over 5mb in size and cannot be previewed

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

Nature
Personal Author:

Konermann, Silvana ; Brigham, Mark D. ; Trevino, Alexandro E. ; Joung, Julia ; Abudayyeh, Omar O. ; ... More +

Konermann, Silvana ; Brigham, Mark D. ; Trevino, Alexandro E. ; Joung, Julia ; Abudayyeh, Omar O. ; Barcena, Clea ; Hsu, Patrick D. ; Habib, Naomi ; Gootenberg, Jonathan S. ; Nishimasu, Hiroshi ; Nureki, Osamu ; Zhang, Feng Less -
Description:

Systematic interrogation of gene function requires the ability to perturb gene expression in a robust and generalizable manner. Here we describe structure-guided engineering of a CRISPR-Cas9 complex to mediate efficient transcriptional activation at endogenous genomic loci. We used these engineered Cas9 activation complexes to investigate single-guide RNA (sgRNA) targeting rules for effective transcriptional activation, to demonstrate multiplexed activation of ten genes simultaneously, and to upregulate long intergenic non-coding RNA (lincRNA) transcripts. We also synthesized a library consisting of 70,290 guides targeting all human RefSeq coding isoforms to screen for genes that, upon activation, confer resistance to a BRAF inhibitor. The top hits included genes previously shown to be able to confer resistance, and novel candidates were validated using individual sgRNA and complementary DNA overexpression. A gene expression signature based on the top screening hits correlated with markers of BRAF inhibitor resistance in cell lines and patient-derived samples. These results collectively demonstrate the potential of Cas9-based activators as a powerful genetic perturbation technology.
Subjects:

[+]

Cell Line, Tumor Clustered Regularly Interspaced Short Palindromic Repeats CRISPR-Associated Proteins CRISPR-Cas Systems DNA, Complementary Drug Resistance, Neoplasm Gene Expression Regulation, Neoplastic Gene Library Genetic Engineering Genetic Loci Genetic Testing Genome, Human Humans Indoles Melanoma Proto-Oncogene Proteins B-raf Reproducibility Of Results RNA, Untranslated Sulfonamides Transcriptional Activation Up-Regulation
Source:

Nature. 517(7536):583-588.
Document Type:

Journal Article
Funding:

DP1 MH100706/MH/NIMH NIH HHS/United States ; DP1-MH100706/DP/NCCDPHP CDC HHS/United States ; R01 NS062849/NS/NINDS NIH HHS/United States ; R01 NS073124/NS/NINDS NIH HHS/United States ; R01-NS07312401/NS/NINDS NIH HHS/United States

DP1 MH100706/MH/NIMH NIH HHS/United States ; DP1-MH100706/DP/NCCDPHP CDC HHS/United States ; R01 NS062849/NS/NINDS NIH HHS/United States ; R01 NS073124/NS/NINDS NIH HHS/United States ; R01-NS07312401/NS/NINDS NIH HHS/United States Less -
Volume:

517
Issue:

7536
Collection(s):

CDC Public Access
Main Document Checksum:

[+]

urn:sha256:00240015f8e83fdc18d2356f7aaa2060e230d14be0f83ff74a6b8bda785ee102
Download URL:

https://stacks.cdc.gov/view/cdc/30833/cdc_30833_DS1.pdf
File Type:

	nihms681876f11.gif	gif
	nihms681876f11.jpg	jpeg
	nihms681876f12.gif	gif
	nihms681876f12.jpg	jpeg
	nihms681876f13.gif	gif
	nihms681876f13.jpg	jpeg
	nihms681876f14.gif	gif
	nihms681876f14.jpg	jpeg
	nihms681876f15.gif	gif
	nihms681876f15.jpg	jpeg
	NIHMS681876-supplement-SuppInfo.pdf	pdf
	nihms681876f16.gif	gif
	nihms681876f16.jpg	jpeg
	nihms681876f17.jpg	jpeg
	nihms681876f2.gif	gif
	nihms681876f2.jpg	jpeg
	nihms681876f3.gif	gif
	nihms681876f3.jpg	jpeg
	nihms681876f4.gif	gif
	nihms681876f4.jpg	jpeg
	nihms681876f5.gif	gif
	NIHMS681876-supplement-SuppTable6.csv	csv
	nihms681876f5.jpg	jpeg
	nihms681876f6.gif	gif
	nihms681876f6.jpg	jpeg
	nihms681876f7.gif	gif
	nihms681876f7.jpg	jpeg
	nihms681876f8.gif	gif
	nihms681876f8.jpg	jpeg
	nihms681876f9.gif	gif
	nihms681876f9.jpg	jpeg
	NIHMS681876-supplement-SuppTable7.csv	csv
	nihms681876.nxml	txt
	nihms681876f1.gif	gif
	nihms681876f1.jpg	jpeg
	nihms681876f10.gif	gif
	nihms681876f10.jpg	jpeg

More +